Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression
详细信息 查看全文
- 作者：Salomé S Pinho (1) (2)
Augusto JF Matos (2)
Célia Lopes (2)
Nuno T Marcos (1)
Júlio Carvalheira (2)
Celso A Reis (1) (3)
Fátima G?rtner (1) (2) - 刊名：BMC Cancer
- 出版年：2007
- 出版时间：December 2007
- 年：2007
- 卷：7
- 期：1
- 全文大小：1233KB
- 参考文献：1. Sorenmo K: ass="a-plus-plus">Canine mammary gland tumors. / Vet Clin Small Anim 2003, ass="a-plus-plus">33: 573-96. <a class="external" href="http://dx.doi.org/10.1016/S0195-5616(03)00020-2">CrossRefa>
2. Owen LN: ass="a-plus-plus">A comparative study of canine and human breast cancer. / Invest Cell Pathol 1979, ass="a-plus-plus">2: 257-75.
3. Kurzman ID, Gilbertson SR: ass="a-plus-plus">Prognostic factors in canine mammary tumors. / Seminars in Veterinary Medicine and Surgery (Small Animal) 1986, ass="a-plus-plus">1: 25-2.
4. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N: ass="a-plus-plus">Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. / Cancer Sci 2004, ass="a-plus-plus">95: 377-84. <a class="external" href="http://dx.doi.org/10.1111/j.1349-7006.2004.tb03219.x">CrossRefa>
5. Hakomori S: ass="a-plus-plus">Tumour malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. / Cancer Res 1996, ass="a-plus-plus">56: 5309-318.
6. Borsig L, Wong R, Hynes RO, Varki NM, Varki A: ass="a-plus-plus">Synergistic effects of l- and p-selectin in facilitating tumour metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. / Proc Natl Acad Sci 2002, ass="a-plus-plus">99: 2193-198. <a class="external" href="http://dx.doi.org/10.1073/pnas.261704098">CrossRefa>
7. Fukuda M: ass="a-plus-plus">Possible roles of tumour-associated carbohydrate antigens. / Cancer Res 1996, ass="a-plus-plus">56: 2237-244.
8. Numahata K, Satoh M, Handa K, Saito S, Ohyama C, Ito A, Takahashi T, Hoshi S, Orikasa S, Hakomori S: ass="a-plus-plus">Sialosyl-le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">expression defines invasive and metastatic properties of bladder carcinoma. / Cancer 2002, ass="a-plus-plus">94: 673-85. <a class="external" href="http://dx.doi.org/10.1002/cncr.10268">CrossRefa>
9. Wang PH: ass="a-plus-plus">Altered glycosylation in cancer: sialic acids and sialyltransferases. / J Cancer Mol 2005, ass="a-plus-plus">1: 73-1.
10. Hakomori S: ass="a-plus-plus">Glycosylation defining cancer malignancy: new wine in an old bottle. / Proc Natl Acad Sci 2002, ass="a-plus-plus">99: 10231-0233. <a class="external" href="http://dx.doi.org/10.1073/pnas.172380699">CrossRefa>
11. Ono M, Hakomori S: ass="a-plus-plus">Glycosylation defining cancer cell motility and invasiveness. / Glycoconj J 2004, ass="a-plus-plus">20: 71-8. <a class="external" href="http://dx.doi.org/10.1023/B:GLYC.0000018019.22070.7d">CrossRefa>
12. Dube DH, Bertozzi CR: ass="a-plus-plus">Glycans in cancer and inflammation -potential for therapeutics and diagnostics. / Nature Reviews 2005, ass="a-plus-plus">4: 477-88. <a class="external" href="http://dx.doi.org/10.1038/nrd1751">CrossRefa>
13. Monzavi-Karbassi B, Whitehead TL, Jousheghany F, Artaud C, Hennings L, Shaaf S, Slaughter A, Korourian S, Kelly T, Blaszczyk-Thurin M, Kieber-Emmons T: ass="a-plus-plus">Deficiency in surface expression of e-selectin ligand promotes lung colonization in a mouse model of breast cancer. / Int J Cancer 2005, ass="a-plus-plus">117: 398-08. <a class="external" href="http://dx.doi.org/10.1002/ijc.21192">CrossRefa>
14. Ugorski M, Laskowska A: ass="a-plus-plus">Sialyl lewis ass="a-plus-plus"> ass="a-plus-plus">a ass="a-plus-plus">: a tumour-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells. / Acta Bioch Polon 2002, ass="a-plus-plus">49: 303-11.
15. Magnani JL: ass="a-plus-plus">The discovery, biology, and drug development of sialyl le ass="a-plus-plus"> ass="a-plus-plus">a ass="a-plus-plus">and sialyl le and le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">. / Arch Biochem Biophys 2004, ass="a-plus-plus">426: 122-31. <a class="external" href="http://dx.doi.org/10.1016/j.abb.2004.04.008">CrossRefa>
16. Varki A: ass="a-plus-plus">Selectin ligands. / Proc Natl Acad Sci USA 1994, ass="a-plus-plus">91: 7390-397. <a class="external" href="http://dx.doi.org/10.1073/pnas.91.16.7390">CrossRefa>
17. Sawada R, Tsuboi S, Fukuda M: ass="a-plus-plus">Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. / J Biol Chem 1994, ass="a-plus-plus">269: 1425-431.
18. Kannagi R: ass="a-plus-plus">Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. / Glycoconjugate J 2004, ass="a-plus-plus">20: 353-64. <a class="external" href="http://dx.doi.org/10.1023/B:GLYC.0000033631.35357.41">CrossRefa>
19. Dabelsteen E: ass="a-plus-plus">Cell surface carbohydrates as prognostic markers in human carcinomas. / J Pathol 1996, ass="a-plus-plus">179: 358-69. <a class="external" href="http://dx.doi.org/10.1002/(SICI)1096-9896(199608)179:4<358::AID-PATH564>3.0.CO;2-T">CrossRefa>
20. Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, Ayabe H, Hara S, Ishikawa H, Minami H: ass="a-plus-plus">Expression of abh/lewis-related antigens as prognostic factors in patients with breast cancer. / J Cancer Res Clin Oncol 2002, ass="a-plus-plus">128: 257-64. <a class="external" href="http://dx.doi.org/10.1007/s00432-002-0334-5">CrossRefa>
21. Matsuura N, Narita T, Mitsuoka C, Kimura N, Kannagi R, Imai T, Funahashi H, Takagi H: ass="a-plus-plus">Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. / Jpn J Clin Oncol 1997, ass="a-plus-plus">27: 135-39. <a class="external" href="http://dx.doi.org/10.1093/jjco/27.3.135">CrossRefa>
22. Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC: ass="a-plus-plus">Sialyl lewis antigens: association with muc5ac protein and correlation with post-operative recurrence of non-small cell lung cancer. / Lung Cancer 2005, ass="a-plus-plus">47: 59-7. <a class="external" href="http://dx.doi.org/10.1016/j.lungcan.2004.05.018">CrossRefa>
23. Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K: ass="a-plus-plus">Expression of sialyl lewis x, sialyl lewis a, e-cadherin and cathepsin-d in human breast cancer: immunohistochemical analysis in mammary carcinoma ass="a-plus-plus">in situ ass="a-plus-plus">, invasive carcinomas and their lymph node metastasis. / Anticancer Res 2005, ass="a-plus-plus">25: 1615-622.
24. Jorgensen T, Berner A, Kaalhus O, Tveter KJ, Danielsen HE, Bryne M: ass="a-plus-plus">Up-regulation of the oligosaccharide Sialyl Lewis ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">: a new prognostic parameter in metastatic prostate cancer. / Cancer Res 1995, ass="a-plus-plus">55: 1817-819.
25. Grabowski P, Mann B, Mansmann U, L?vin N, Foss HD, Berger G, Scherübl H, Riecken EO, Buhr HJ, Hanski C: ass="a-plus-plus">Expression of Sialyl-Le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">antigen defined by Mab AM-3 is an independent prognostic marker in colorectal carcinoma patients. / Int J Cancer 2000, ass="a-plus-plus">88: 281-86. <a class="external" href="http://dx.doi.org/10.1002/1097-0215(20001015)88:2<281::AID-IJC21>3.0.CO;2-2">CrossRefa>
26. Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T, Shishido T: ass="a-plus-plus">Close correlation between increased sialyl-lewis ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">expression and metastasis in human gastric carcinoma. / World J Surg 1997, ass="a-plus-plus">21: 773-76. <a class="external" href="http://dx.doi.org/10.1007/s002689900304">CrossRefa>
27. Amado M, Carneiro F, Seixas M, Clausen H, Sobrinho-Sim?es M: ass="a-plus-plus">Dimeric Sialyl-Le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">expression in gastric carcinoma correlates with venous invasion and poor outcome. / Gastroenterology 1998, ass="a-plus-plus">114: 462-70. <a class="external" href="http://dx.doi.org/10.1016/S0016-5085(98)70529-3">CrossRefa>
28. Futamura N, Nakamura S, Tatematsu M, Yamamura Y, Kannagi R, Hirose H: ass="a-plus-plus">Clinicopathologic significance of sialyl Le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">expression in advanced gastric carcinoma. / Br J Cancer 2000, ass="a-plus-plus">83: 1681-687. <a class="external" href="http://dx.doi.org/10.1054/bjoc.2000.1484">CrossRefa>
29. Nakagawa T, Uyama R, Ohashi E, Takahashi T, Hong SH, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N: ass="a-plus-plus">The expression of sialyl lewis x in canine and feline mammary gland tumors. / J Vet Med Sci 2002, ass="a-plus-plus">64: 949-52. <a class="external" href="http://dx.doi.org/10.1292/jvms.64.949">CrossRefa>
30. Alpaugh ML, Tomlinson JS, Kasraeian S, Barsky SH: ass="a-plus-plus">Cooperative role of e-cadherin and sialyl-lewis x/a-deficient muc1 in the passive dissemination of tumour emboli in inflammatory breast carcinoma. / Oncogene 2002, ass="a-plus-plus">21: 3631-643. <a class="external" href="http://dx.doi.org/10.1038/sj.onc.1205389">CrossRefa>
31. Alpaugh ML, Tomlinson JS, Ye Y, Barsky SH: ass="a-plus-plus">Relationship of sialyl-lewis ass="a-plus-plus"> ass="a-plus-plus">x/a ass="a-plus-plus">underexpression and e-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. / Am J Pathol 2002, ass="a-plus-plus">161: 619-28.
32. Alpaugh ML, Barsky SH: ass="a-plus-plus">Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. / Hum Gene Ther 2002, ass="a-plus-plus">13: 1245-258. <a class="external" href="http://dx.doi.org/10.1089/104303402320139023">CrossRefa>
33. Matos AJF, Lopes C, Carvalheira J, Santos M, Rutteman GR, G?rtner F: ass="a-plus-plus">E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. / J Comp Path 2006, ass="a-plus-plus">134: 182-89. <a class="external" href="http://dx.doi.org/10.1016/j.jcpa.2005.10.004">CrossRefa>
34. Misdorp W, Else RW, Hellmén E, Lipscomb TP: ass="a-plus-plus">Histological classification of the mammary tumours of the dog and the cat. / World Health Organization International Histological Classification of Tumours of Domestic Animals / (Edited by: Shulman FI). Armed Forces Institute of Pathology, Washington DC 1999, 16-9.
35. Hsu SM, Faine L, Fanger H: ass="a-plus-plus">A comparative study of the peroxidase-antiperoxidase method and the avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. / Am J Clin Pathol 1981, ass="a-plus-plus">75: 734-38.
36. Fukushi Y, Nudelman E, Levery SB, Hakomori S, Rauvala H: ass="a-plus-plus">Novel fucolipids accumulating in human adenocarcinoma: III a hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI ass="a-plus-plus"> ass="a-plus-plus">3 ass="a-plus-plus">NeuAcV ass="a-plus-plus"> ass="a-plus-plus">3 ass="a-plus-plus">III ass="a-plus-plus"> ass="a-plus-plus">3 ass="a-plus-plus">Fuc ass="a-plus-plus"> ass="a-plus-plus">2 ass="a-plus-plus">nLc ass="a-plus-plus"> ass="a-plus-plus">6 ass="a-plus-plus">). / J Biol Chem 1984, ass="a-plus-plus">259: 10511-0517.
37. SAS Institute Inc: ass="a-plus-plus">SAS/STAT ass="a-plus-plus"> ass="a-plus-plus">? ass="a-plus-plus">User's Guide, Version 6. / Fourth Edition Cary, NC: SAS Institute Inc 1989, ass="a-plus-plus">1: 943.
38. Kannagi R: ass="a-plus-plus">Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. / Glycoconj J 1997, ass="a-plus-plus">14: 577-84. <a class="external" href="http://dx.doi.org/10.1023/A:1018532409041">CrossRefa>
39. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Hiraki A, Sasaki M, Beppu M, Shirasuna K: ass="a-plus-plus">Immunohistochemical study of sialyl le ass="a-plus-plus"> ass="a-plus-plus">a ass="a-plus-plus">and sialyl le ass="a-plus-plus"> ass="a-plus-plus">x ass="a-plus-plus">antigen in oral squamous cell carcinoma: the association of sialyl le ass="a-plus-plus"> ass="a-plus-plus">a ass="a-plus-plus">expression with the metastatic potential. / Head Neck 1999, ass="a-plus-plus">21: 330-37. <a class="external" href="http://dx.doi.org/10.1002/(SICI)1097-0347(199907)21:4<330::AID-HED7>3.0.CO;2-#">CrossRefa>
40. Farmer RW, Richtsmeier WJ, Scher RL: ass="a-plus-plus">Identification of sialyl lewis-x in squamous cell carcinoma of head and neck. / Head Neck 1998, ass="a-plus-plus">20: 726-31. <a class="external" href="http://dx.doi.org/10.1002/(SICI)1097-0347(199812)20:8<726::AID-HED11>3.0.CO;2-C">CrossRefa>
41. Nakagawa T, Watanabe M, Ohashi E, Uyama R, Takauji S, Mochizuki M, Nishimura R, Ogawa H, Sugano S, Sasaki N: ass="a-plus-plus">Cyclopedic protein expression analysis of cultured canine mammary gland adenocarcinoma cells from six tumours. / Res Vet Sci 2006, ass="a-plus-plus">80: 317-23. <a class="external" href="http://dx.doi.org/10.1016/j.rvsc.2005.07.011">CrossRefa>
42. Pe?a L, Perez-Alenza D, Rodriguez-Bertos A, Nieto A: ass="a-plus-plus">Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. / Breast Cancer Res Treat 2003, ass="a-plus-plus">78: 141-48. <a class="external" href="http://dx.doi.org/10.1023/A:1022991802116">CrossRefa>
43. Benjamin SA, Lee AC, Saunders WJ: ass="a-plus-plus">Classification and behaviour of canine mammary epithelial neoplasms based on life-span observations in beagles. / Vet Pathol 1999, ass="a-plus-plus">36: 423-36. <a class="external" href="http://dx.doi.org/10.1354/vp.36-5-423">CrossRefa>
44. Bostock DE: ass="a-plus-plus">The prognosis following the surgical excision of canine mammary neoplasms. / Europ J Cancer 1975, ass="a-plus-plus">11: 389-96.
45. Parham DM, Hagen N, Brown RA: ass="a-plus-plus">Simplified method of grading primary carcinomas of the breast. / J Clin Pathol 1992, ass="a-plus-plus">45: 517-20. <a class="external" href="http://dx.doi.org/10.1136/jcp.45.6.517">CrossRefa>
46. Gilchrist KW, Gray R, Fowble B, Tormey DC, Taylor SG: ass="a-plus-plus">Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. / J Clin Oncol 1993, ass="a-plus-plus">11: 1929-935.
47. Carlomagno C, Perrone F, Lauria R, de Laurentiis M, Gallo C, Morabito A, Pettinato G, Panico L, bellelli T, Apicella A: ass="a-plus-plus">Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. / Oncology 1995, ass="a-plus-plus">52: 272-77. <a class="external" href="http://dx.doi.org/10.1159/000227472">CrossRefa>
48. Liotta LA, Stetler-Stevenson WG, Steeg PS: ass="a-plus-plus">Cancer invasion and metastasis: positive and negative regulatory elements. / Cancer Invest 1991, ass="a-plus-plus">9: 543-51. <a class="external" href="http://dx.doi.org/10.3109/07357909109018952">CrossRefa>
49. Brunetti B, Sarli G, Preziosi R, Monari I, Benazzi C: ass="a-plus-plus">E-Cadherin expression in canine mammary carcinomas with regional lymph node metastases. / J Vet Med 2003, ass="a-plus-plus">50: 496-00. <a class="external" href="http://dx.doi.org/10.1111/j.1439-0442.2003.00577.x">CrossRefa>
50. Birchmeier W, Behrens J: ass="a-plus-plus">Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. / Biochim Biophys Acta 1994, ass="a-plus-plus">1198: 11-6.
51. The pre-publication history for this paper can be accessed here:<a href="http://www.biomedcentral.com/1471-2407/7/124/prepub" class="a-plus-plus">http://www.biomedcentral.com/1471-2407/7/124/prepuba> - 作者单位：Salomé S Pinho (1) (2)
Augusto JF Matos (2)
Célia Lopes (2)
Nuno T Marcos (1)
Júlio Carvalheira (2)
Celso A Reis (1) (3)
Fátima G?rtner (1) (2)
1. Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Dr Roberto Frias s/n, 4200-465, Porto, Portugal
2. Institute of Biomedical Sciences of Abel Salazar (ICBAS), University of Porto, Largo Prof. Abel Salazar, 2, 4099-003, Porto, Portugal
3. Medical Faculty, University of Porto, Alameda Prof. Hernani Monteiro, 4200-319, Porto, Portugal - ISSN：1471-2407
文摘
Background Sialyl Lewis x (sLex) antigen is a carbohydrate antigen that is considered not only a marker for cancer but also implicated functionally in the malignant behaviour of cancer cells. Overexpression of sLex is associated with enhanced progression and metastases of many types of cancer including those of the mammary gland. Canine mammary tumours can invade and give rise to metastases via either lymphatic or blood vessels. E-Cadherin is specifically involved in epithelial cell-to-cell adhesion. In cancer, E-Cadherin underexpression is one of the alterations that characterizes the invasive phenotype and is considered an invasion/tumour suppressor gene. Partial or complete loss of E-Cadherin expression correlates with poor prognosis in canine malignant mammary cancer. The aim of this study was to analyse the sLex expression in canine malignant mammary tumours and to evaluate if the presence of sLex correlates with the expression of E-Cadherin and with clinicopathological features. Methods Fifty-three cases of canine mammary carcinomas were analysed immunohistochemically using monoclonal antibodies against sLex (IgM) and E-Cadherin (IgG). The clinicopathological data were then assessed to determine whether there was a correlation with sLex tumour expression. Double labelled immunofluorescence staining was performed to analyse the combined expression of sLex and E-Cadherin. Results sLex expression was consistently demonstrated in all cases of canine mammary carcinomas with different levels of expression. We found a significant relationship between the levels of sLex expression and the presence of lymph node metastases. We also demonstrated that when E-Cadherin expression was increased sLex was reduced and vice-versa. The combined analysis of both adhesion molecules revealed an inverse relationship. Conclusion In the present study we demonstrate the importance of sLex in the malignant phenotype of canine malignant mammary tumours. Our results support the use of sLex as a prognostic tumour marker in canine mammary carcinomas. Furthermore, we showed that sLex and E-Cadherin expression were inversely correlated. Future studies are warranted to clarify the molecular mechanism underlying the relation between sLex and E-Cadherin in canine mammary carcinoma cells which represents an important comparative model to woman breast cancer.